发布求助
文献互助 智能选刊 最新文献

Oncology Times UK最新文献

筛选
英文 中文
Standardization & Harmonization of Immuno-Oncology Toxicities 免疫肿瘤毒性的标准化与协调
Oncology Times UK Pub Date : 2021-04-05 DOI: 10.1097/01.COT.0000743548.22737.F7
P. Eastman
{"title":"Standardization & Harmonization of Immuno-Oncology Toxicities","authors":"P. Eastman","doi":"10.1097/01.COT.0000743548.22737.F7","DOIUrl":"https://doi.org/10.1097/01.COT.0000743548.22737.F7","url":null,"abstract":"","PeriodicalId":19642,"journal":{"name":"Oncology Times UK","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88460688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 Risks for Patients Receiving Chemotherapy Treatment 接受化疗患者的COVID-19风险
Oncology Times UK Pub Date : 2021-04-05 DOI: 10.1097/01.COT.0000743588.21595.58
Warren Froelich
{"title":"COVID-19 Risks for Patients Receiving Chemotherapy Treatment","authors":"Warren Froelich","doi":"10.1097/01.COT.0000743588.21595.58","DOIUrl":"https://doi.org/10.1097/01.COT.0000743588.21595.58","url":null,"abstract":"","PeriodicalId":19642,"journal":{"name":"Oncology Times UK","volume":"36 1","pages":"34-34"},"PeriodicalIF":0.0,"publicationDate":"2021-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73838954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Detection of Axillary Adenopathy After a COVID-19 Vaccine 新冠肺炎疫苗接种后腋窝腺病变的检测
Oncology Times UK Pub Date : 2021-04-05 DOI: 10.1097/01.COT.0000743564.78189.FC
L. Nolen
{"title":"The Detection of Axillary Adenopathy After a COVID-19 Vaccine","authors":"L. Nolen","doi":"10.1097/01.COT.0000743564.78189.FC","DOIUrl":"https://doi.org/10.1097/01.COT.0000743564.78189.FC","url":null,"abstract":"","PeriodicalId":19642,"journal":{"name":"Oncology Times UK","volume":"44 1","pages":"16-17"},"PeriodicalIF":0.0,"publicationDate":"2021-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77627917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel Agents Show Promise in Diffuse Large B-Cell Lymphoma 新型药物有望治疗弥漫性大b细胞淋巴瘤
Oncology Times UK Pub Date : 2021-04-05 DOI: 10.1097/01.COT.0000743584.65169.1E
M. Fuerst
{"title":"Novel Agents Show Promise in Diffuse Large B-Cell Lymphoma","authors":"M. Fuerst","doi":"10.1097/01.COT.0000743584.65169.1E","DOIUrl":"https://doi.org/10.1097/01.COT.0000743584.65169.1E","url":null,"abstract":"","PeriodicalId":19642,"journal":{"name":"Oncology Times UK","volume":"AES-20 1","pages":"32-32"},"PeriodicalIF":0.0,"publicationDate":"2021-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84580769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relugolix As First Oral GnRH Antagonist Option for Prostate Cancer Relugolix作为治疗前列腺癌的首选口服GnRH拮抗剂
Oncology Times UK Pub Date : 2021-04-05 DOI: 10.1097/01.COT.0000743572.96757.38
M. Schneider
{"title":"Relugolix As First Oral GnRH Antagonist Option for Prostate Cancer","authors":"M. Schneider","doi":"10.1097/01.COT.0000743572.96757.38","DOIUrl":"https://doi.org/10.1097/01.COT.0000743572.96757.38","url":null,"abstract":"","PeriodicalId":19642,"journal":{"name":"Oncology Times UK","volume":"53 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83414665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Database of HPV-Negative Head & Neck Carcinomas Unveiled hpv阴性头颈癌新数据库公布
Oncology Times UK Pub Date : 2021-04-05 DOI: 10.1097/01.COT.0000743560.21748.B8
C. Holt
{"title":"New Database of HPV-Negative Head & Neck Carcinomas Unveiled","authors":"C. Holt","doi":"10.1097/01.COT.0000743560.21748.B8","DOIUrl":"https://doi.org/10.1097/01.COT.0000743560.21748.B8","url":null,"abstract":"","PeriodicalId":19642,"journal":{"name":"Oncology Times UK","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82078947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent Trends & Innovations in Oncology 肿瘤学的最新趋势和创新
Oncology Times UK Pub Date : 2021-03-20 DOI: 10.1097/01.COT.0000741756.80231.AA
V. Hackethal
{"title":"Recent Trends & Innovations in Oncology","authors":"V. Hackethal","doi":"10.1097/01.COT.0000741756.80231.AA","DOIUrl":"https://doi.org/10.1097/01.COT.0000741756.80231.AA","url":null,"abstract":"","PeriodicalId":19642,"journal":{"name":"Oncology Times UK","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79953120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lack of PSA Screening Increased Metastatic Prostate Cancer 缺乏PSA筛查增加转移性前列腺癌
Oncology Times UK Pub Date : 2021-03-20 DOI: 10.1097/01.COT.0000741780.69111.97
M. Fuerst
{"title":"Lack of PSA Screening Increased Metastatic Prostate Cancer","authors":"M. Fuerst","doi":"10.1097/01.COT.0000741780.69111.97","DOIUrl":"https://doi.org/10.1097/01.COT.0000741780.69111.97","url":null,"abstract":"","PeriodicalId":19642,"journal":{"name":"Oncology Times UK","volume":"206 1","pages":"32-32"},"PeriodicalIF":0.0,"publicationDate":"2021-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76066483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study Finds COVID Fatality Rate Variance Based on Cancer Subtypes 研究发现基于癌症亚型的COVID致死率差异
Oncology Times UK Pub Date : 2021-03-20 DOI: 10.1097/01.COT.0000741772.88693.D3
Warren Froelich
{"title":"Study Finds COVID Fatality Rate Variance Based on Cancer Subtypes","authors":"Warren Froelich","doi":"10.1097/01.COT.0000741772.88693.D3","DOIUrl":"https://doi.org/10.1097/01.COT.0000741772.88693.D3","url":null,"abstract":"","PeriodicalId":19642,"journal":{"name":"Oncology Times UK","volume":"31 1","pages":"28-30"},"PeriodicalIF":0.0,"publicationDate":"2021-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88832913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in the Treatment of Patients With R/R Follicular Lymphoma R/R滤泡性淋巴瘤的治疗进展
Oncology Times UK Pub Date : 2021-03-20 DOI: 10.1097/01.COT.0000741736.66789.EC
D. Das
{"title":"Advances in the Treatment of Patients With R/R Follicular Lymphoma","authors":"D. Das","doi":"10.1097/01.COT.0000741736.66789.EC","DOIUrl":"https://doi.org/10.1097/01.COT.0000741736.66789.EC","url":null,"abstract":"","PeriodicalId":19642,"journal":{"name":"Oncology Times UK","volume":"7 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84180112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信